DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Raz I, Hanefeld M, Xu L et al.
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus.
Diabetologia 2006;
49 (11) 2564-2571
http://www.ncbi.nlm.nih.gov/pubmed/17001471
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.